AcuCort receives market approval from the Finnish Medicines Agency for the drug Zeqmelit®
AcuCort has received approval for the company's first drug Zeqmelit® in Finland from the Finnish drug monitoring agency, Fimea. Thus, Zeqmelit® has been approved in all Nordic countries."An important milestone for the upcoming market launch of Zeqmelit® in the Nordics is achieved with this approval. We look with great confidence to the upcoming launch in the Nordics and continue the work to register Zeqmelit® in other prioritized markets", says Jonas Jönmark, CEO of AcuCort. In the development of the drug Zeqmelit®, AcuCort has succeeded in combining the advantages of the well-